Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 826, doi. 10.1007/s00262-004-0650-5
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 9
Results: 12
1
2
Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 815, doi. 10.1007/s00262-004-0649-y
- By:
- Publication type:
- Article
3
Role of tumor-derived transforming growth factor-β1 (TGF-β1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 837, doi. 10.1007/s00262-004-0656-z
- By:
- Publication type:
- Article
4
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 858, doi. 10.1007/s00262-004-0646-1
- By:
- Publication type:
- Article
5
Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 907, doi. 10.1007/s00262-004-0660-3
- By:
- Publication type:
- Article
6
Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 891, doi. 10.1007/s00262-004-0654-1
- By:
- Publication type:
- Article
7
Transforming growth factor-β<sub>1</sub> immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 898, doi. 10.1007/s00262-004-0652-3
- By:
- Publication type:
- Article
8
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 915, doi. 10.1007/s00262-004-0638-1
- By:
- Publication type:
- Article
9
Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 848, doi. 10.1007/s00262-005-0661-x
- By:
- Publication type:
- Article
10
Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 926, doi. 10.1007/s00262-005-0677-2
- By:
- Publication type:
- Article
11
Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 867, doi. 10.1007/s00262-005-0666-5
- By:
- Publication type:
- Article
12
Exposure to the electrofusion process can increase the immunogenicity of human cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 9, p. 880, doi. 10.1007/s00262-004-0659-9
- By:
- Publication type:
- Article